Cumulus Neuroscience is a startup based in the United Kingdom, most recent round Series A.
Based in the United Kingdom, Cumulus Neuroscience is a startup. Its most recent tracked round is Series A.
Cumulus Neuroscience develops the NeuLogiq Platform, which uses a dry-sensor EEG headset and AI-powered tablet assessments to measure brain function across multiple domains, including cognition, mood, and language, enabling more efficient and objective data collection in neuroscience clinical trials and patient care.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.